232 related articles for article (PubMed ID: 28759403)
1. Metformin for Obesity in Prepubertal and Pubertal Children: A Randomized Controlled Trial.
Pastor-Villaescusa B; Cañete MD; Caballero-Villarraso J; Hoyos R; Latorre M; Vázquez-Cobela R; Plaza-Díaz J; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
Pediatrics; 2017 Jul; 140(1):. PubMed ID: 28759403
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial.
Pastor-Villaescusa B; Caballero-Villarraso J; Cañete MD; Hoyos R; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
Trials; 2016 Jul; 17(1):323. PubMed ID: 27432166
[TBL] [Abstract][Full Text] [Related]
3. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.
Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
Pediatr Diabetes; 2015 Nov; 16(7):538-45. PubMed ID: 25332100
[TBL] [Abstract][Full Text] [Related]
4. Two-Year Treatment With Metformin During Puberty Does Not Preserve β-Cell Function in Youth With Obesity.
Kelsey MM; Hilkin A; Pyle L; Severn C; Utzschneider K; Van Pelt RE; Zeitler PS; Nadeau KJ
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2622-e2632. PubMed ID: 33728428
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study.
Bassols J; Martínez-Calcerrada JM; Osiniri I; Díaz-Roldán F; Xargay-Torrent S; Mas-Parés B; Dorado-Ceballos E; Prats-Puig A; Carreras-Badosa G; de Zegher F; Ibáñez L; López-Bermejo A
PLoS One; 2019; 14(12):e0226303. PubMed ID: 31821361
[TBL] [Abstract][Full Text] [Related]
6. Metformin in obese children and adolescents: the MOCA trial.
Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
[TBL] [Abstract][Full Text] [Related]
7. Metformin in the Management of Childhood Obesity: A Randomized Control Trial.
Warnakulasuriya LS; Fernando MMA; Adikaram AVN; Thawfeek ARM; Anurasiri WL; Silva RR; Sirasa MSF; Rytter E; Forslund AH; Samaranayake DL; Wickramasinghe VP
Child Obes; 2018; 14(8):553-565. PubMed ID: 30070925
[TBL] [Abstract][Full Text] [Related]
8. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.
Yanovski JA; Krakoff J; Salaita CG; McDuffie JR; Kozlosky M; Sebring NG; Reynolds JC; Brady SM; Calis KA
Diabetes; 2011 Feb; 60(2):477-85. PubMed ID: 21228310
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the gut microbiota after metformin intervention in children with obesity: A metagenomic study of a randomized controlled trial.
Pastor-Villaescusa B; Plaza-Díaz J; Egea-Zorrilla A; Leis R; Bueno G; Hoyos R; Vázquez-Cobela R; Latorre M; Cañete MD; Caballero-Villarraso J; Gil Á; Cañete R; Aguilera CM
Biomed Pharmacother; 2021 Feb; 134():111117. PubMed ID: 33360047
[TBL] [Abstract][Full Text] [Related]
10. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal associations between cardiovascular biomarkers and metabolic syndrome during puberty: the PUBMEP study.
González-Gil EM; Anguita-Ruiz A; Kalén A; De Las Lamas Perez C; Rupérez AI; Vázquez-Cobela R; Flores K; Gil A; Gil-Campos M; Bueno G; Leis R; Aguilera CM
Eur J Pediatr; 2023 Jan; 182(1):419-429. PubMed ID: 36376521
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin on energy intake and satiety in obese children.
Adeyemo MA; McDuffie JR; Kozlosky M; Krakoff J; Calis KA; Brady SM; Yanovski JA
Diabetes Obes Metab; 2015 Apr; 17(4):363-70. PubMed ID: 25483291
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
[TBL] [Abstract][Full Text] [Related]
14. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.
Srinivasan S; Ambler GR; Baur LA; Garnett SP; Tepsa M; Yap F; Ward GM; Cowell CT
J Clin Endocrinol Metab; 2006 Jun; 91(6):2074-80. PubMed ID: 16595599
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
[TBL] [Abstract][Full Text] [Related]
16. Leptin and Leptin-to-Adiponectin Ratio Predict Adiposity Gain in Nonobese Children over a Six-Year Period.
Zhang M; Cheng H; Zhao X; Hou D; Yan Y; Cianflone K; Li M; Mi J
Child Obes; 2017 Jun; 13(3):213-221. PubMed ID: 28128972
[TBL] [Abstract][Full Text] [Related]
17. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A; Nicolaides KH; Balani J; Hyer S; Akolekar R; Kotecha R; Pastides A; Shehata H
N Engl J Med; 2016 Feb; 374(5):434-43. PubMed ID: 26840133
[TBL] [Abstract][Full Text] [Related]
18. Importance of plasma leptin in predicting future weight gain in obese children: a two-and-a-half-year longitudinal study.
Savoye M; Dziura J; Castle J; DiPietro L; Tamborlane WV; Caprio S
Int J Obes Relat Metab Disord; 2002 Jul; 26(7):942-6. PubMed ID: 12080447
[TBL] [Abstract][Full Text] [Related]
19. Strong effect of pubertal status on metabolic health in obese children: a longitudinal study.
Reinehr T; Wolters B; Knop C; Lass N; Holl RW
J Clin Endocrinol Metab; 2015 Jan; 100(1):301-8. PubMed ID: 25243573
[TBL] [Abstract][Full Text] [Related]
20. A 24-month metformin treatment study of children with obesity: Changes in circulating GDF-15 and associations with changes in body weight and visceral fat.
Carreras-Badosa G; Gómez-Vilarrubla A; Mas-Parés B; Martínez-Calcerrada JM; Xargay-Torrent S; Prats-Puig A; Puerto-Carranza E; Díaz-Roldán F; de Zegher F; Ibañez L; Bassols J; López-Bermejo A
Pediatr Obes; 2022 Feb; 17(2):e12845. PubMed ID: 34427052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
